Related references
Note: Only part of the references are listed.Old and new facts about hyperthermia-induced modulations of the immune system
Benjamin Frey et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2012)
The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner
Arnt-Ove Hovden et al.
PLOS ONE (2012)
Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
Barbara Morandi et al.
PLOS ONE (2012)
How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
Yvonne Rubner et al.
Frontiers in Oncology (2012)
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands
J. Ruiterkamp et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Else M. Inderberg Suso et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization
Y. Nakamoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1α
Noriho Iida et al.
CANCER RESEARCH (2010)
OK432-activated human dendritic cells kill tumor cells via CD40/CD40 ligand interactions
Katy S. Hill et al.
JOURNAL OF IMMUNOLOGY (2008)
Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety
Y. Nakamoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2006)
Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies
PC Simmonds et al.
BRITISH JOURNAL OF CANCER (2006)
Mechanism of anticancer host response induced by OK-432, a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling
M Okamoto et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation
M Okamoto et al.
CANCER RESEARCH (2004)
In situ tumor ablation creates an antigen source for the generation of antitumor immunity
MHMGM den Brok et al.
CANCER RESEARCH (2004)
Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B
Y Nakamoto et al.
CANCER RESEARCH (2004)
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
G Ferlazzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
JM Timmerman et al.
BLOOD (2002)
Share Paper
